1. 3009 Activity of rociletinib in EGFR mutant NSCLC patients with a history of CNS involvement. (September 2015) Authors: Varga, A.; Camidge, D.R.; Sequist, L.V.; Wakelee, H.; Ou, S.H.; Goldman, J.W.; Papadimitrakopoulou, V.; Gadgeel, S.; Mekhail, T.; Oxnard, G.R.; Socinski, M.; Solomon, B.; Yu, H.; Matheny, S.; Despain, D.; Soria, J.C. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S598 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 3104 Rociletinib treatment and outcomes in non-small cell lung cancer (NSCLC) patients with negative central testing for T790M. (September 2015) Authors: Solomon, B.; Wakelee, H.; Sequist, L.V.; Gadgeel, S.; Soria, J.C.; Goldman, J.W.; Yu, H.; Camidge, D.R.; Papadimitrakopoulou, V.; Matheny, S.; Despain, D.; Besse, B. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S636 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. STRO‐001, A NOVEL ANTI‐CD74 ANTIBODY DRUG CONJUGATE (ADC) FOR TREATMENT OF B‐CELL NON‐HODGKIN'S LYMPHOMAS (NHL). (June 2017) Authors: Molina, A.; Yu, A.; Abrahams, C.; Embry, M.; Li, X.; DeAlmeida, V.; Lee, J.; Matheny, S.; Kline, T.; Yam, A.; Stafford, R.; Hallam, T.; Lupher, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗